A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in 23and Me Holding Co. stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,088,861 shares of ME stock, worth $9.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,088,861
Previous 4,226,779 26.92%
Holding current value
$9.92 Million
Previous $1.65 Million 34.41%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.29 - $0.51 $329,996 - $580,338
-1,137,918 Reduced 26.92%
3,088,861 $1.08 Million
Q2 2024

Aug 09, 2024

SELL
$0.36 - $0.61 $223,697 - $379,043
-621,382 Reduced 12.82%
4,226,779 $1.65 Million
Q1 2024

May 13, 2024

BUY
$0.4 - $0.91 $548,040 - $1.25 Million
1,370,100 Added 39.39%
4,848,161 $2.58 Million
Q4 2023

Feb 13, 2024

BUY
$0.71 - $0.97 $469,239 - $641,073
660,900 Added 23.46%
3,478,061 $3.18 Million
Q3 2023

Nov 14, 2023

BUY
$0.96 - $2.01 $296,094 - $619,948
308,432 Added 12.29%
2,817,161 $2.75 Million
Q2 2023

Aug 11, 2023

BUY
$1.59 - $2.29 $1.55 Million - $2.24 Million
977,329 Added 63.82%
2,508,729 $4.39 Million
Q1 2023

May 12, 2023

BUY
$2.05 - $2.87 $1.87 Million - $2.62 Million
914,500 Added 148.24%
1,531,400 $3.49 Million
Q4 2022

Feb 13, 2023

SELL
$2.06 - $3.47 $1.22 Million - $2.05 Million
-590,400 Reduced 48.9%
616,900 $1.33 Million
Q3 2022

Nov 14, 2022

SELL
$2.6 - $5.12 $4.75 Million - $9.35 Million
-1,826,300 Reduced 60.2%
1,207,300 $3.45 Million
Q2 2022

Aug 12, 2022

BUY
$2.19 - $3.98 $2.25 Million - $4.08 Million
1,025,200 Added 51.05%
3,033,600 $7.52 Million
Q1 2022

May 13, 2022

BUY
$3.28 - $7.12 $6.59 Million - $14.3 Million
2,008,400 New
2,008,400 $7.69 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $834M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.